Corline Biomedical AB's market cap is currently kr484.92M. The company's EPS TTM is kr-0.133; its P/E ratio is -19.42; Corline Biomedical AB is scheduled to report earnings on August 26, 2025, and the estimated EPS forecast is kr―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24
Dec 23
Dec 22
Dec 21
Dec 20
Currency in SEK
Corline Biomedical AB Earnings and Revenue History
